Global partnership to fund groundbreaking research in treatment of multiple myeloma

Groundbreaking research aimed at translating novel Chimeric Antigen Receptor (CAR) T-cell therapies into improved treatment for multiple myeloma is the latest Australian research to be funded through the prestigious Translational Research Program (TRP). Now into its sixth year, this international collaboration between The Leukemia & Lymphoma Society (LLS) and the Snowdome Foundation has supported ten … Continued

Snowdome Foundation | 2024 Making an Impact

On 16 May, we hosted ‘Making an Impact’, a continuation of our series of educational events designed to highlight and showcase the latest in blood cancer research, technologies and next-generation treatments. In 2024, the event was focused specifically on myeloma; a type of blood cancer that has gained a lot of media attention lately, due … Continued

A Legacy of Hope

Gillian has always led a life filled with purpose and passion. From her early days as a school teacher to her 25-year stint in the publishing business, she has never shied away from taking on new challenges. But it was a deeply personal tragedy that truly defined her philanthropic journey and inspired her to leave … Continued

Striving for equitable access to life-changing treatment for myeloma patients

Geoff Nyssen, a devoted husband and father of two, has faced a decade-long journey with blood cancer. Diagnosed with multiple myeloma in 2014 at the age of 40, Geoff faced an uphill journey full of uncertainty and challenges. Over the years, Geoff has undergone a myriad of treatments, each presenting its own set of challenges. … Continued

Interview with Helen Buckingham OAM

We recently sat down with Snowdome Board Director, Helen Buckingham OAM, to get her thoughts on the funding of a new immunotherapy treatment for myeloma, and how clinicians and patients can have their say.

‘Future of cancer treatment’ has just been approved

Reproduced from The Australian 7 June 2023 Natasha Robinson – Health Editor A new treatment, dubbed “the future of cancer therapy”, has been approved to treat a type of blood cancer in a step doctors are hailing as the beginning of a “total paradigm shift” in cancer care for the sickest patients who have failed … Continued